DOI:

Left ventricular angiogram in a patient with noncompaction cardiomyopathy

Kadir Caliskan*, MD; Randall N. de Visser, MD; Robert-Jan van Geuns, MD, PhD; Folkert J. Ten Cate, MD, PhD; P.W. Serruys, MD, PhD

A 50-year-old female was referred for cardiac screening because of the sudden cardiac death of her 48 year-old brother. She had no cardiopulmonary complaints and her physical examination was unremarkable.

Electrocardiography demonstrated sinus rhythm and normal QRS duration without any repolarisation abnormality.

A 24-hours Holter monitoring revealed sinus rhythm and no ventricular arrhythmias. Echocardiography disclosed a moderately diminished, diffuse left ventricular dysfunction with suspected hypertrophy of apical, mid-posterior end mid-inferior ventricular walls.

Patient subsequently underwent left heart catheterisation to exclude ischaemic cardiomyopathy. Coronary angiography showed normal coronary arteries. Left ventricular angiogram (LV) in right anterior oblique projection (figure 1 and movie 1) showed an excessively prominent trabecular zone with a spongy appearance of the myocardium in apical, inferior and anterior and to a lesser extent the posterolateral segment. These findings were highly suspicious of a left ventricular noncompaction or noncompaction cardiomyopathy (NCCM), which was confirmed by subsequent contrast echocardiography (figure 2), multislice CT-scan (figure 3) and magnetic resonance imaging (MRI) of the heart (figure 4 and movie 2).

Figure 1. Left ventricular angiogram of this patient showing extensive hypertrabeculation, mostly of the apical segments.

Figure 2. Two-dimensional contrast echocardiography of the apical four-chamber view: excessive and prominent trabeculation of the left ventricle apical segments is visible. Communication between the recesses and ventricular cavity is clearly demonstrated with a contrast agent.

Figure 3. Multislice CT-scan of the LV ventricle showing excessive and prominent trabeculations; the short line delineates the compacted area, and the longer line, the noncompacted area.

Figure 4. Four chamber MRI view of the heart, demonstrating the hypertrabeculation of apical and lateral walls of the left ventricle; the ratio of noncompacted to compacted myocardium is here a maximum of five.

NCCM is as yet a rare, unclassified form of cardiomyopathy.1 Incidence of this unique cardiomyopathy is estimated to be 0.05% in adults. It is characterised by excessively thickened, irregular endocardial surfaces with prominent trabeculations and intertrabecular recesses. Patients with NCCM can be either asymptomatic develop systolic dysfunction with heart failure, supra-ventricular and / or (lethal) ventricular arrhythmias or systemic thrombo-emboli.2

As this disease is not widely known, its diagnosis is frequently missed or misclassified.

The standard diagnostic procedure for NCCM is two-dimensional echocardiography with colour Doppler studies. In case of a planned diagnostic heart catheterisation or impaired echocardiographic imaging quality, an LV angiogram can be helpful in further diagnostic process.

References

Volume 2 Number 4
Feb 20, 2007
Volume 2 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00648 Jul 20, 2026
When less is no longer more: very early aspirin discontinuation after ACS
Piccolo R and Vitale A
free

Editorial

10.4244/EIJ-E-26-00010 Jul 20, 2026
Aspirin withdrawal after primary PCI for STEMI: timing matters
Paradies V and Mancini G
free

Editorial

10.4244/EIJ-D-26-00715 Jul 20, 2026
Endotype-guided management of ANOCA: are we ready?
Montone R
free

Original Research

10.4244/EIJ-D-26-00148 Jul 20, 2026
Endotype-guided medical therapy and symptom response in ANOCA
Farina J et al

Research Correspondence

10.4244/EIJ-D-25-01215 Jul 20, 2026
Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention
Crooijmans C et al

Flashlight

10.4244/EIJ-D-25-00731 Jul 20, 2026
Collapse of a new-generation magnesium scaffold
Bastante T et al
Trending articles
335.05

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
49.35

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
45.5

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.15

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved